%0 Journal Article
%T Treatment of Triple-Negative Breast Cancer Cells with the Canady Cold Plasma Conversion System: Preliminary Results
%A Alexey Shashurin
%A Barry Trink
%A Giacomo Basadonna
%A Jerome Canady
%A Lawan Ly
%A Michael Keidar
%A Shruti Wigh
%A Taisen Zhuang
%A Warren Rowe
%A Xiaoqian Cheng
%J -
%D 2018
%R https://doi.org/10.3390/plasma1010019
%X Abstract Triple-negative breast cancer is a phenotype of breast cancer where the expression level of estrogen, progesterone and human epidermal growth factor receptor 2 (HER2) receptors are low or absent. It is more frequently diagnosed in younger and premenopausal women, among which African and Hispanic have a higher rate. Cold atmospheric plasma has revealed its promising ant-cancer capacity over the past two decades. In this study, we report the first cold plasma jet delivered by the Canady Cold Plasma Conversion Unit and characterization of its electric and thermal parameters. The unit effectively reduced the viability of triple-negative breast cancer up to 80% without thermal damage, providing a starting point for future clinical trials. View Full-Tex
%K triple-negative breast cancer
%K cold atmospheric plasma
%K cold plasma device
%U https://www.mdpi.com/2571-6182/1/1/19